These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7442412)

  • 1. Influence of sulphone therapy on lepromin reaction.
    Ramu G; Sengupta U; Desikan KV
    Lepr Rev; 1980 Sep; 51(3):207-14. PubMed ID: 7442412
    [No Abstract]   [Full Text] [Related]  

  • 2. A preliminary report on a therapeutic trial with acedapsone in lepromatous leprosy.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):85-7. PubMed ID: 1100969
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with acedapsone (DADDS) in the therapeutic trial in New Guinea and the chemoprophylactic trial in Micronesia.
    Russell DA; Worth RM; Scott GC; Vincin DR; Jano B; Fasal P; Shepard CC
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):170-6. PubMed ID: 776853
    [No Abstract]   [Full Text] [Related]  

  • 4. The number of Mycobacterium leprae in the pretreatment biopsy-specimen does not determine the rate of response of patients with lepromatous leprosy to chemotherapy with acedapsone.
    Levy L; Shepard CC
    Lepr Rev; 1986 Mar; 57(1):27-31. PubMed ID: 3517535
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Prevention of leprosy by acedapsone.
    Russell DA; Worth RM; Jano B; Fasal P; Shepard CC
    Lancet; 1975 Oct; 2(7938):771. PubMed ID: 52800
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood dapsone levels in leprosy patients treated with acedapsone.
    George J; Balakrishnan S
    Indian J Lepr; 1986; 58(3):401-6. PubMed ID: 3794408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and effective serum level of repository sulphones (DADDS) in lepromatous leprosy.
    Anand LC; Rathore BS
    Lepr India; 1979 Jul; 51(3):358-62. PubMed ID: 513651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprophylaxis against leprosy with acedapsone.
    Neelan PN; Noordeen SK; Sivaprasad N
    Indian J Med Res; 1983 Sep; 78():307-13. PubMed ID: 6674153
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoprophylaxis against leprosy with acedapsone. An interim report.
    Noordeen SK; Neelan PN; Munaf A
    Lepr India; 1980 Jan; 52(1):97-103. PubMed ID: 6991817
    [No Abstract]   [Full Text] [Related]  

  • 10. Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia.
    Russell DA; Worth RM; Jano B; Fasal P; Shepard CC
    Am J Trop Med Hyg; 1979 May; 28(3):559-63. PubMed ID: 453449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acedapsone treatment of leprosy patients: response versus drug disposition.
    Peters JH; Murray JF; Gordon GR; Levy L; Russell DA; Scott GC; Vincin DR; Shepard CC
    Am J Trop Med Hyg; 1977 Jan; 26(1):127-36. PubMed ID: 842774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug therapy for leprosy in Trinidad and Tobago: a preliminary report.
    Keeler RF
    Lepr Rev; 1984 Dec; 55(4):391-6. PubMed ID: 6396477
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited duration acedapsone prophylaxis in leprosy.
    Neelan PN; Sirumban P; Sivaprasad N
    Indian J Lepr; 1986; 58(2):251-6. PubMed ID: 3543161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trials of preventive therapy.
    Blanc LJ
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S7-9. PubMed ID: 10700928
    [No Abstract]   [Full Text] [Related]  

  • 15. Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1975 May; 24(3):485-95. PubMed ID: 1098496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precipitation of type-I (upgrading) reaction in leprosy by skin testing with antigen and irritants.
    Malhotra B; Das KD; Tutakne MA; Aggarwal SK
    Lepr India; 1983 Apr; 55(2):305-9. PubMed ID: 6632784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of paucibacillary leprosy patients released from control relapsing with multibacillary leprosy.
    Jesudasan K; Christian M
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):19-21. PubMed ID: 3998560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO expert committee on leprosy.
    World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriologic study in patients with multibacillary leprosy treated with rifampicin and acedapsone].
    Olivares Sabournin R; González Segredo AB
    Rev Cubana Med Trop; 1989; 41(2):307-12. PubMed ID: 2486227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.